Both in Biotechnology
Immunovant vs CRISPR Therapeutics AG
Over the past year IMVT returned +23.8% and CRSP returned −15.9%; their daily moves had a correlation of 0.41.
IMVT +23.8% CRSP −15.9%Growth of $1, one year, split-adjusted
| Metric | IMVT | CRSP |
|---|---|---|
| Price | $29.44 | $52.10 |
| Market cap | $6.08B | $5.04B |
| Today | +1.36% | +4.22% |
| 1 month | −8.3% | −3.5% |
| 6 months | +2.7% | −5.4% |
| Year to date | +15.8% | −0.6% |
| 1 year | +23.8% | −15.9% |
| Revenue growth (YoY) | — | +1325.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −879.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 200.1× |
| Net cash | $797.8M | $1.69B |
| Dividend yield | — | — |
| Volatility (60d) | 37.1% | 53.8% |
| Short % of float | 21.1% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).